Is Coherus Oncology, Inc. (CHRS) a Buy, Sell, or Hold?
NASDAQ : CHRS
Coherus Oncology, Inc.
$1.44 USD
-$0.01 (-0.69%)
- Volume
- 627.74K
- Average Volume
- 1.16M
- Market Capitalization
- $176.27M
- P/E Ratio
- -1.12
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $2.62
- Year Low
- $0.81
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.56
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.21%
Investors Holding
7
change: -154 | last: 161
Increased Positions
3
change: -88 | last: 91
Reduced Positions
3
change: -32 | last: 35
New Positions
1
change: -41 | last: 42
Sold Positions
151
change: 139 | last: 12
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -485.91 | last: 4.8591
Total Invested
406.83K
CHRS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.42 | 120.37M | $170.92M | $88.88M | $40.34M | $122.38M |
| 2024-12-31 | $1.38 | 114.55M | $158.08M | $125.99M | $269.9M | $302M |
| 2023-12-31 | $3.33 | 94.16M | $313.56M | $102.89M | $480.84M | $691.51M |
| 2022-12-31 | $7.92 | 77.63M | $614.83M | $63.55M | $480.42M | $1.03B |
| 2021-12-31 | $15.96 | 75.45M | $1.2B | $417.2M | $419.02M | $1.21B |
| 2020-12-31 | $17.38 | 71.41M | $1.24B | $541.16M | $417.1M | $1.12B |
| 2019-12-31 | $18.01 | 69.68M | $1.25B | $177.67M | $188.64M | $1.27B |
| 2018-12-31 | $9.05 | 65.01M | $588.36M | $72.36M | $103.09M | $619.1M |
| 2017-12-31 | $8.80 | 53.13M | $467.58M | $126.91M | $101.41M | $442.07M |
| 2016-12-31 | $28.15 | 41.91M | $1.18B | $124.95M | $100.26M | $1.16B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1.69 | 136.4M | $230.51M | $115.24M | $54.37M | $169.65M |
| 2025-12-31 | $1.42 | 120.37M | $170.92M | $88.88M | $40.34M | $122.38M |
| 2025-09-30 | $1.64 | 116.23M | $190.62M | $103.35M | $40.69M | $127.96M |
| 2025-06-30 | $0.73 | 116.08M | $84.89M | $216.89M | $41.03M | -$90.98M |
| 2025-03-31 | $0.81 | 115.86M | $93.5M | $82.41M | $269.93M | $281.01M |
| 2024-12-31 | $1.38 | 115.42M | $159.28M | $125.99M | $269.9M | $303.19M |
| 2024-09-30 | $1.04 | 115.21M | $119.82M | $97.69M | $269.88M | $292M |
| 2024-06-30 | $1.61 | 114.82M | $184.86M | $159.24M | $298.34M | $323.96M |
| 2024-03-31 | $2.40 | 112.75M | $270.6M | $259.78M | $481.16M | $491.99M |
| 2023-12-31 | $3.33 | 111.49M | $371.27M | $102.89M | $480.84M | $749.22M |
| 2023-09-30 | $3.74 | 97.74M | $365.54M | $80.71M | $478.68M | $763.51M |
| 2023-06-30 | $4.27 | 87.27M | $372.64M | $73.36M | $479.26M | $778.54M |